维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="WYSOCKI PJ"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Primary resistance to do- cetaxel - based chemotherapy in metastatic breast cancer patients cor- relates with a high frequency of BRCA1 mutations显示文摘	Wysocki PJ Korski K Lamperska K	2008	Med Sci Monit2008，14，7：	1
2	Pri- mary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations 显示文摘	WYSOCKI PJ KORSKI K LAMPERSKA K	2005	Med Sci Monit2005，14，7：	1
3	New therspeutic options in systemic treatment of advanced cutaneous melanoma显示文摘	Mackiewicz-Wysocka M Zolnierek J Wysocki PJ	2013	Expert Opin Investig Drugs2013，22，2：	1
4	mTOR in renal cell cancer:modulator of tumor biology and therapeutic target显示文摘	Wysocki PJ	2009	Expert Rev Mol Diagn2009，9，3：	1
5	Progress in the treatment of bone metastases in cancer patients 显示文摘	Mackiewicz - Wysocka Pankowska M Wysocki PJ	2012	Expert Opin Investig Drngs2012，21，6：	1
6	Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations 显示文摘	Wysocki PJ Korski K Lamperska K	2008	Med Sci Monit2008，14，7：	1
7	Recent developments in retroviral gene delivery systems显示文摘	Wysocki PJ Grabarczyk P Mackiewicz A	2001	Expert Opin Biol Ther2001，1，6：	1
8	Pro-gress in the treatment of bone metastases tients显示文摘	Mackiewicz-Wysocka M Pankowska M Wysocki PJ		Expert Opinion on Investigational0，21，6：	1
9	Recent developments in renal cell cancer immunotherapy 显示文摘	Wysocki PJ Zolnierek J Szczylik C	2007	Expert Opin Biol Ther2007，7，5：	1
10	Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA1 mutations显示文摘	Wysocki Pj Korski K Lamperska K		0，，07：	1
11	Primary resistance to docetaxel-based chemotherapy in metastatic breast cancer patients correlates with a high frequency of BRCA 1mutations显示文摘	WYSOCKI PJ KORSKI K LAMPERSKA K	2008	Med Sci Monit2008，14，7：	1
12	New therapeutic options in systemic treatment of advanced cutaneous melanoma显示文摘	Mackiewicz-Wysocka M Zolnierek J Wysocki PJ	2013	Expert Opin Investig Drugs2013，22，2：	1
13	Progress in the treatment of bone metastases in cancer patients显示文摘	Mackiewicz-Wysocka M Pankowska M Wysocki PJ	2012	Expert Opin Investig Drugs2012，21，6：	1
14	mTOR in the renal cell cancer: modulator of the tumor biology and therapeutic target显示文摘	Wysocki PJ	2009	Expert Revmol Diaqn2009，9，3：	1
15	m TOR in renal cell cancer:modulator of tumor biology and therapeutic target显示文摘	Wysocki PJ	2009	Expert Rev Mol Diagn2009，9，：	1
16	Recent developments in retroviral gene delivery systems显示文摘	Wysocki PJ Grabarczyk P Mackiewicz A	2001	Expert Opin Biol Ther2001，1，：	1
17	Human cancer gene therapy with cytokine gene-modified cells显示文摘	Wysocki PJ Karczewska-Dzionk A Mackiewicz-Wysocka M	2004	Expert Opin Biol Ther2004，4，10：	1
18	mTOR in renal cell cancer: modulator of tumor biology and therapeutic target 显示文摘	Wysocki PJ	2009	Expert Rev Mol Diagn2009，9，3：	1
19	mTOR in renal cell cancer:modulator of tumor biologyand therapeutic target 显示文摘	Wysocki PJ	2009	Expert Rev Mol Diagn2009，9，3：	1
20	Progress in the treatment of bone metastases in cancer patients显示文摘	Mackiewicz-Wysocka M Pankowska M Wysocki PJ	2012	Expert Opin Investig Drugs2012，21，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示